Percentage of hepatitis C virus-infected hepatocytes is a better predictor of response than serum viremia levels

Journal of Molecular Diagnostics

Volumn 7, Issue 4, 2005, Pages 535-543

  Rodríguez Iñigo, Elena ^a   López Alcorocho, Juan Manuel ^a   Bartolomé, Javier ^a   Ortiz Movilla, Nuria ^a   Pardo, Margarita ^a   Carreño, Vicente ^a  

^a Fundacion para el Estudio de Las Hepatitis Virales   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIVER BIOPSY; LIVER CELL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; QUANTITATIVE ANALYSIS; ROC CURVE; VIREMIA;

HEPATITIS C VIRUS;

EID: 26944488011     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60585-5     Document Type: Article

References (35)

1. World Health Organization: Hepatitis C. Wkly Epidemiol Rec 1997, 72:65-69
2. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001, 358:958-965
3. Bruno S, Camma C, Di Marco V, Rumi M, Vinci M, Camozzi M, Rebucci C, Di Bona D, Colombo M, Craxi A, Mondelli MU, Pinzello G: Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial. J Hepatol 2004, 41:474-481
4. Shiffman ML, Di Bisceglie AM, Lindsay KL, Morishima C, Wright EC, Everson GT, Lok AS, Morgan TR, Bonkovsky HL, Lee WM, Dienstag JL, Ghany MG, Goodman ZD, Everhart JE; Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group: Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology 2004, 126:1015-1923
5. Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, Bodenheimer H Jr, Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM; PEGASYS International Study Group: Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004, 140:346-355
6. Yuki N, Hayashi N, Kasahara A, Hagiwara H, Takehara T, Oshita M, Katayama K, Fusamoto H, Kamada T: Pretreatment viral load and response to prolonged interferon-alpha course for chronic hepatitis C. J Hepatol 1995, 22:457-463
7. Garson JA, Brillanti S, Whitby K, Foli M, Deaville R, Masci C, Miglioli M, Barbara L: Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C. J Med Virol 1995, 45:348-353
8. Lindsay KL, Davis GL, Schiff ER, Bodenheimer HC, Balart LA, Dienstag JL, Perrillo RP, Tamburro CH, Goff JS, Everson GT, Silva M, Katkov WN, Goodman Z, Lau JY, Maertens G, Gogate J, Sanghvi B, Albrecht J: Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group. Hepatology 1996, 24:1034-1040
9. Pawlotsky JM, Bouvier-Alias M, Hezode C, Darthuy F, Remire J, Dhumeaux D: Standardization of hepatitis C virus RNA quantification. Hepatology 2000, 32:654-659
10. Davis GL, Lau JY, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, Perrillo RP, Albrecht J: Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994, 19:1337-1341
11. Lau JY, Simmonds P, Urdea MS: Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 1995, 346:425-426
12. McNicol AM, Farquharson MA: In situ hybridization and its diagnostic applications in pathology. J Pathol 1997, 182:250-261
13. Höfler H, Childers H, Montminy MR, Lecham RM, Goodmann RH, Wolfe HJ: In situ hybridization methods for the detection of somatostain mRNA in tissue sections using antisense RNA probes. Histochem J 1986, 18:597-604
14. Chang M, Williams O, Mittler J, Quintanilla A, Carithers RL Jr, Perkins J, Corey L, Gretch DR: Dynamics of hepatitis C virus replication in human liver. Am J Pathol 2003, 163:433-444
15. Rodriguez-Inigo E, Bartolome J, de Lucas S, Manzarbeitia F, Pardo M, Arocena C, Gosalvez J, Oliva H, Carreno V: Histological damage in chronic hepatitis C is not related to the extent of infection in the liver. Am J Pathol 1999, 154:1877-1881
16. de Lucas S, Bartolome J, Rodriguez-Inigo E, Casqueiro M, Millan A, Ruiz-Moreno M, Oliva H, Carreno V: Distribution of hepatitis C virus infection in liver biopsies from children and adults with chronic hepatitis C. J Med Virol 2001, 64:1-5
17. Gosalvez J, Rodriguez-Inigo E, Ramiro-Diaz JL, Bartolome J, Tomas JF, Oliva H, Carreno V: Relative quantification and mapping of hepatitis C virus by in situ hybridization and digital image analysis. Hepatology 1998, 27:1428-1434
18. Castillo I, Pardo M, Bartolome J, Ortiz-Movilla N, Rodriguez-Iñigo E, de Lucas S, Salas C, Jimenez-Heffernan JA, Perez-Mota A, Graus J, Lopez-Alcorocho JM, Carreño V: Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004, 189:7-14
19. Bedossa P: Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C: METAVIR Cooperative Study Group. Hepatology 1994, 20:15-20
20. Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C: The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293
21. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C: Hepatitis Interventional Therapy Group. N Engl J Med 1998, 339:1485-1492
22. Gervais A, Martinot M, Boyer N, Auperin A, Le Breton W, Degott C, Valla D, Marcellin P: Quantitation of hepatic hepatitis C virus RNA in patients with chronic hepatitis C: relationship with severity of disease, viral genotype and response to treatment. J Hepatol 2001, 35:399-405
23. Madejon A, Manzano ML, Arocena C, Castillo I, Carreno V: Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus RNA strands. J Hepatol 2000, 32:1019-1025
24. Angerer LM, Angerer RC: Detection of poly A+ RNA in sea urchin eggs and embryos by quantitative in situ hybridization. Nucleic Acids Res 1981, 9:2819-2840
25. Singer RH, Ward DC: Actin gene expression visualized in chicken muscle tissue culture by using in situ hybridization with a biotinated nucleotide analog. Proc Natl Acad Sci USA 1982, 79:7331-7335
26. Lawrence JB, Singer RH: Quantitative analysis of in situ hybridization methods for the detection of actin gene expression. Nucleic Acids Res 1985, 13:1777-1799
27. Idrovo V, Dailey PJ, Jeffers LJ, Coelho-Little E, Bernstein D, Bartholomew M, Alvarez L, Urdea MS, Collins ML, Schiff ER: Hepatitis C virus RNA quantification in right and left lobes of the liver in patients with chronic hepatitis C. J Viral Hepat 1996, 3:239-246
28. Terrault NA, Dailey PJ, Ferrell L, Collins ML, Wilber JC, Urdea MS, Bhandari BN, Wright TL: Hepatitis C virus: quantitation and distribution in liver. J Med Virol 1997, 51:217-224
29. Fanning L, Loane J, Kenny-Walsh E, Sheehan M, Whelton M, Kirwan W, Collins JK, Shanahan F: Tissue viral load variability in chronic hepatitis C. Am J Gastroenterol 2001, 96:3384-3389
30. Agnello V, Abel G, Knight GB, Muchmore E: Detection of widespread hepatocyte infection in chronic hepatitis C. Hepatology 1998, 28:573-584
31. Negro F, Pacchioni D, Shimizu Y, Miller RH, Bussolati G, Purcell RH, Bonino F: Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. Proc Natl Acad Sci USA 1992, 89:2247-2251
32. Lamas E, Baccarini P, Housset C, Kremsdorf D, Brechot C: Detection of hepatitis C virus (HCV) RNA sequences in liver tissue by in situ hybridization. J Hepatol 1992, 16:219-223
33. National Institute of Health. Consensus development conference panel statement: management of hepatitis C. Hepatology 1997, 26(Suppl 1):2S-10S
34. The British Society of Gastroenterology: Guidelines on the use of liver biopsy in clinical practice. Gut 1999, 45(Suppl 4):1-11
35. European Association for the Study of the Liver. Consensus statement EASL: International Conference on Hepatitis C. J Hepatol 1999, 31(Suppl 1):3-8